22-09-2026 17:27 via drugs.com

Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL

TUESDAY, Sept. 22, 2026-- Blinatumomab is associated with significantly higher event-free survival among children with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), according to a study published in the Sept. 17 issue of the...
Read more »

Pharmaceutical Industry news



High Intake of Eggs, Peanuts in Pregnancy Does Not Lower Allergy Risk
Gene Mutation Identified That Increases Lung Cancer Risk
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis
Cirrhosis Can Recur After Liver Transplant
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
Intrauterine Instillation of Mepivacaine Reduces Pain of IUD Placement
Nighttime Light Exposure Linked to Sleep Parameters in Schizophrenia
Structured Exercise Should Be Considered as Adjunct Therapy for Cancer
Socioeconomic Status Linked to Mortality After Acute Hip Fracture Surgery
Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance
Altered Markers of Ovarian Development Seen With Fetal Acetaminophen Exposure
Desktop versie